STAAR Surgical Company (STAA)
Return on assets (ROA)
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | -20 | 21,347 | 39,665 | 27,511 | 5,913 |
Total assets | US$ in thousands | 509,524 | 488,692 | 415,148 | 345,778 | 257,416 |
ROA | -0.00% | 4.37% | 9.55% | 7.96% | 2.30% |
December 31, 2024 calculation
ROA = Net income ÷ Total assets
= $-20K ÷ $509,524K
= -0.00%
STAAR Surgical Company's return on assets (ROA) has shown significant fluctuations over the past five years. In December 31, 2020, the ROA was 2.30%, indicating that the company generated a profit of 2.30 cents for every dollar of assets it owns. This figure increased to 7.96% by December 31, 2021, reflecting an improvement in the company's ability to generate earnings from its assets.
The ROA continued to rise to 9.55% by December 31, 2022, reaching its peak during this period. This suggests that the company was efficiently utilizing its assets to generate profits. However, there was a notable decline in the ROA to 4.37% by December 31, 2023, indicating a decrease in profitability relative to the previous year.
Interestingly, by December 31, 2024, the ROA dropped to -0.00%, implying that the company did not generate any profit from its assets during this period. This could be a cause for concern as it suggests that the company may have incurred losses or faced challenges in generating earnings from its assets.
Overall, STAAR Surgical Company's ROA has demonstrated variability over the years, with both positive and negative movements. It is essential for stakeholders to closely monitor the company's management of assets and profitability to ensure sustainable performance in the future.
Peer comparison
Dec 31, 2024